Therefore, the purpose of treating lung cancer stem-like cells (hA549) with the supernatants of IL-2 and anti-CD16 antibody NK cells in the current study was to determine if IL-2 and anti-CD16 antibody-treated NK cells can mediate the differentiation of lung cancer stem-like cells as well. This evidence concerns the gene IL2 and lung carcinoma.